Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Author Banthin, Jessica S.
Title Trends in the use and expenditures for COX-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs, 1997-2003 / Jessica Banthin and Marc Zodet.
Imprint [Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2006]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.6517/10:139    ONLINE  
LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.6517/10:139    ONLINE  
Author Banthin, Jessica S.
Series Statistical brief ; #139.
Statistical brief (Medical Expenditure Panel Survey (U.S.)) ; #139.
Subject Nonsteroidal anti-inflammatory agents.
Cyclooxygenase 2 -- Inhibitors.
Cyclooxygenase 2 Inhibitors -- economics.
Anti-Inflammatory Agents, Non-Steroidal -- economics.
United States.
Alt Name Zodet, Marc.
United States. Agency for Healthcare Research and Quality.
Medical Expenditure Panel Survey (U.S.)
Description 6 unnumbered pages : digital, PDF file.
monochrome rdacc
System Details Mode of access: Internet from the MEPS AHRQ web site. Address as of 9/18/2008: http://www.meps.ahrq.gov/mepsweb/data%5Ffiles/publications/st139/stat139.pdf ; current access available via PURL.
Note Title from title screen (viewed Sept. 18, 2008).
"September 2006."
Bibliography Note Includes bibliographical references.
Summary This Statistical Brief uses data from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) to document trends in use and expenditures for COX-2 inhibitors from 1997 to 2003 in relation to trends for traditional NSAIDS.
OCLC # 76790551


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team